Development of a reporter gene method to measure the bioactivity of anti-CD38 × CD3 bispecific antibody

BACKGROUND: A T cell-redirecting bispecific antibody (bsAb) consisting of a tumor-binding unit and a T cell-binding unit is a large group of antibody-based biologics against death-causing cancer diseases. The anti-CD38 × anti-CD3 bsAb (Y150) is potential for treating multiple myeloma (MM). When deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Hui, Luo, Fengyan, Zhou, Pengfei, Yi, Jizu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524643/
https://www.ncbi.nlm.nih.gov/pubmed/34676357
http://dx.doi.org/10.1093/abt/tbab022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524643/
https://www.ncbi.nlm.nih.gov/pubmed/34676357
http://dx.doi.org/10.1093/abt/tbab022

Ejemplares similares